کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2478259 | 1113346 | 2011 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Conjoncture d'approvisionnement et essor de l'imagerie TEP : quel avenir pour le technétium-99m en médecine nucléaire ?
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Molecular imaging has shown its interest in the diagnosis, staging and therapy monitoring of many diseases, especially in the field of cancer. This imaging modality can detect non-invasively early molecular changes specific to these diseases. Its expansion includes two aspects linked firstly with the advanced techniques of imaging modalities and secondly with the development of tracers as radio pharmaceuticals for imaging new molecular targets. Technetium-99m (99mTc), because of its physical characteristics, its widespread availability and low cost, is the most used radionuclide in molecular imaging with the technique of single photon emission computed tomography (SPECT). Nevertheless, the current difficulty concerning the supply and the great interest of Positron Emission Tomography (PET), the “competitor” imaging modality-using molecules labelled with fluorine-18 (18F), legitimates the question about the future of 99mTc, its supremacy and the emergence of new tracer labelled with 99mTc. Focusing on the actual and future supply situation, the place of SPECT imaging in nuclear medicine, as well as the development of new molecules labelled with 99mTc is necessary to show that this radionuclide will remain essential for the speciality in the next years.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Annales Pharmaceutiques Françaises - Volume 69, Issue 3, May 2011, Pages 155-164
Journal: Annales Pharmaceutiques Françaises - Volume 69, Issue 3, May 2011, Pages 155-164
نویسندگان
S. Maia, N. Ayachi Hatit, F. Paycha,